Multiple Myeloma Cure: Who Could Be Cured and What Does Cure Mean? | IMS 2026

Fredrik Schjesvold, MD, PhD, of Oslo Myeloma Center discusses how close the field is to curing myeloma at IMS 2026 in Glasgow. He walks through the new IMS and IMWG cure definition and why being cured means being off treatment. He explains why moving fixed-duration immunotherapies like CAR-T and bispecific antibodies into earlier lines could raise the still unknown share of patients who are cured, and why he believes high-risk disease, while less likely to be cured, does not rule it out.

0:00 Intro
0:21 Have we cured myeloma before?
0:57 The new IMS/IMWG definition of cure
1:44 Cure in later lines and frontline treatment
3:02 Can high-risk patients stop treatment?
4:29 Will fewer patients be considered high risk?

If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/628617/src=htu

For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!

Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.